Skip to main content

Advertisement

SpringerLink
Log in

FDG-PET of patients with suspected renal failure: standardized uptake values in normal tissues

  • SHORT COMMUNICATION
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

This study aims to clarify the effect of renal function on 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) imaging and determine the clinical significance of renal function in this setting. We compared FDG distribution between normal volunteers and patients with suspected renal failure.

Methods

Twenty healthy volunteers and 20 patients with suspected renal failure who underwent FDG-PET between November 2002 and May 2005 were selected for this study. We define “patients with suspected renal failure” as having a blood serum creatinine level in excess of 1.1 mg/dl. The serum creatinine level was examined once in 2 weeks of the FDG-PET study. Regions of interest were placed over 15 regions for semi-quantitative analysis: the white matter, cortex, both upper lung fields, both middle lung fields, both lower lung fields, mediastinum, myocardium of the left ventricle, the left atrium as a cardiac blood pool, central region of the right lobe of the liver, left kidney, and both femoris muscles.

Results

The mean standardized uptake values (SUVs) of brain cortex and white matter were higher in healthy volunteers than in renal patients. The mean SUVs of the mediastinum at the level of the aortic arch and left atrium as a cardiac blood pool were lower in healthy volunteers than in patients with suspected renal failure. These regions differed between healthy volunteers and patients with suspected renal failure (P < 0.05).

Conclusions

We found decreasing brain accumulation and increasing blood pool accumulation of FDG in patients with high plasma creatinine. Although the difference is small, this phenomenon will not have a huge effect on the assessment of FDG-PET imaging in patients with suspected renal failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. LG Straus PS Conti (1991) ArticleTitleThe applications of PET in clinical oncology J Nucl Med 32 623–48

    Google Scholar 

  2. BM Gallagher JS Flowler NI Gutterson RR MacGregor CN Wan AP Wolf et al. (1978) ArticleTitleMetabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F]2-deoxy-2-fluoro-d-glucose J Nucl Med 19 1154–61 Occurrence Handle214528 Occurrence Handle1:CAS:528:DyaE1MXisVKi

    PubMed  CAS  Google Scholar 

  3. K Hamacher HH Coenen G Stocklin (1986) ArticleTitleEfficient stereospecific synthesis of non-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution J Nucl Med 27 235–8 Occurrence Handle3712040 Occurrence Handle1:CAS:528:DyaL2sXhvV2ntA%3D%3D

    PubMed  CAS  Google Scholar 

  4. P Lindholm H Minn S Leskinen-Kallio J Bergman U Ruotsalainen H Joensun et al. (1993) ArticleTitleInfluence of the blood glucose concentration on FDG uptake in cancer: a PET study J Nucl Med 34 1–6 Occurrence Handle8418248 Occurrence Handle1:STN:280:DyaK3s7hsFOruw%3D%3D

    PubMed  CAS  Google Scholar 

  5. D Delbeke C Meyerowitz RL Lapidus (1995) ArticleTitleOptimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET Radiology 195 47–52 Occurrence Handle7892494 Occurrence Handle1:STN:280:DyaK2M7pvFGrsg%3D%3D

    PubMed  CAS  Google Scholar 

  6. N Plaquet A Albert J Foidart R Hustinx (2004) ArticleTitleWithin-patient variability of [18F]-FDG: standardized uptake values in normal tissues J Nucl Med 45 784–8

    Google Scholar 

  7. Guyton AC, Hall JE. Textbook of medical physiology, chap 27. 11th ed. WB Saunders Philadelphia

  8. Harney JV, Wahl RL, Liebert M, Kuhl DE, Hutchins GD, Nilsson S, et al. Uptake of 2-deoxy-2-[18F]-fluoro-d-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urol 1991;279–83

  9. H Ahlstrom PU Malmstrom H Letocha J Andersson B Langstrom et al. (1996) ArticleTitlePositron emission tomography in the diagnosis and staging of urinary bladder cancer Acta Radiol 37 180–5 Occurrence Handle8600958 Occurrence Handle1:STN:280:DyaK287nvVyqsg%3D%3D

    PubMed  CAS  Google Scholar 

  10. S Kosuda PV Kison R Greenough HB Grossman RL Wahl (1997) ArticleTitlePreliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer Eur J Nucl Med 24 615–20 Occurrence Handle9169567 Occurrence Handle1:STN:280:DyaK2szhtleqtA%3D%3D

    PubMed  CAS  Google Scholar 

  11. BM Gallagher A Ansari H Atkins V Casella DR Christman JS Fowler et al. (1977) ArticleTitle[18F]-labeled 2-deoxy-2fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals J Nucl Med 18 990–6 Occurrence Handle903484 Occurrence Handle1:CAS:528:DyaE1cXisVCn

    PubMed  CAS  Google Scholar 

  12. M Walser HH Drew D Norman (1998) ArticleTitleCreatinine measurements often yield false estimates of progression in chronic renal failure Kidney Int 34 412–8 Occurrence Handle10.1038/ki.1988.196

    Article  Google Scholar 

  13. JL Lyman (1986) ArticleTitleBlood urea nitrogen and creatinine Emerg Med Clin North 4 IssueID2 223–33 Occurrence Handle1:STN:280:DyaL287pt1SrsA%3D%3D

    CAS  Google Scholar 

  14. S Kosuda S Fisher RL Wahl (1997) ArticleTitleAnimal studies on the reduction and/or dilution of 2-deoxy-2-[18F] fluoro-d-glucose (FDG) activity in the urinary system Ann Nucl Med 11 IssueID3 213–78 Occurrence Handle9310170 Occurrence Handle1:CAS:528:DyaK2sXntVCltbo%3D Occurrence Handle10.1007/BF03164766

    Article  PubMed  CAS  Google Scholar 

  15. JK Moran HB Lee MD Blaufox (1999) ArticleTitleOptimization of urinary FDG excretion during PET imaging J Nucl Med 40 1352–7 Occurrence Handle10450688 Occurrence Handle1:CAS:528:DyaK1MXlslSktro%3D

    PubMed  CAS  Google Scholar 

  16. RA DeFronzo A Alvestrand D Smith R Hendler E Hendler J Wahren et al. (1981) ArticleTitleInsulin resistance in uremia J Clin Invest 67 563–8 Occurrence Handle7007440 Occurrence Handle1:CAS:528:DyaL3MXotFOitw%3D%3D Occurrence Handle10.1172/JCI110067

    Article  PubMed  CAS  Google Scholar 

  17. B Fruehwald-Schultes W Kern E Deininger P Wellhoener W Kerner J Born et al. (1999) ArticleTitleProtective effect of insulin against hypoglycemia associated counterregulatory failure J Clin Endo Metab 84 1551–7 Occurrence Handle10.1210/jc.84.5.1551 Occurrence Handle1:CAS:528:DyaK1MXjtFClu78%3D

    Article  CAS  Google Scholar 

  18. M Davis M Mellman H Shamoon (1993) ArticleTitlePhysiologic hyperinsulinemia enhances counterregulatory hormone response to hyperglycemia in IDDM J Clin Endo Metab 76 1383–5 Occurrence Handle10.1210/jc.76.5.1383 Occurrence Handle1:STN:280:DyaK3s3ms1Ortg%3D%3D

    Article  CAS  Google Scholar 

  19. B Becker F Kronenberg JT Kielstein H Haller C Morath (2005) ArticleTitleRenal insulin resistance syndrome, adeponectin and cardiovascular events in patients with kidney disease J Am Soc Nephrol 16 1091–8 Occurrence Handle15743998 Occurrence Handle10.1681/ASN.2004090742 Occurrence Handle1:CAS:528:DC%2BD2MXjsVWqt78%3D

    Article  PubMed  CAS  Google Scholar 

  20. EM Bingham D Hopkins D Smith A Pernet W Hallett L Read et al. (2002) ArticleTitleThe role of insulin in human brain glucose metabolism Diabetes 51 3384–90 Occurrence Handle12453890 Occurrence Handle10.2337/diabetes.51.12.3384 Occurrence Handle1:CAS:528:DC%2BD38Xptl2ntbg%3D

    Article  PubMed  CAS  Google Scholar 

  21. SG Hasselbalch GM Knudsen C Videbaek LH Pinborg JF Schmidt S Holm et al. (1999) ArticleTitleNo effect of insulin on glucose blood–brain barrier transport and cerebral metabolism in humans Diabetes 48 1915–21 Occurrence Handle10512354 Occurrence Handle10.2337/diabetes.48.10.1915 Occurrence Handle1:CAS:528:DyaK1MXmsVCjsr8%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan

    Ryogo Minamimoto, Nobukazu Takahashi & Tomio Inoue

Authors
  1. Ryogo Minamimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobukazu Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomio Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryogo Minamimoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minamimoto, R., Takahashi, N. & Inoue, T. FDG-PET of patients with suspected renal failure: standardized uptake values in normal tissues. Ann Nucl Med 21, 217–222 (2007). https://doi.org/10.1007/s12149-007-0012-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0012-4

Key words

Search

Navigation